title: Comparison of ampicillin/sulbactam plus aminoglycoside vs. ampicillin plus clindamycin plus aminoglycoside in the treatment of intraabdominal infections in children. The Multicenter Group.
authors.affiliation: Division of Infectious Diseases, Children's Hospital of Michigan, Detroit 48201, USA.
authors.forename: M D
authors.initials: MD
authors.lastname: Collins
authors.forename: A S
authors.initials: AS
authors.lastname: Dajani
authors.forename: K S
authors.initials: KS
authors.lastname: Kim
authors.forename: D R
authors.initials: DR
authors.lastname: King
authors.forename: S L
authors.initials: SL
authors.lastname: Kaplan
authors.forename: P H
authors.initials: PH
authors.lastname: Azimi
authors.forename: A
authors.initials: A
authors.lastname: Kolokathis
authors.forename: R
authors.initials: R
authors.lastname: Swanson
mesh_terms: D018784:Abdominal Abscess / Q000188:drug therapy* / Q000382:microbiology; D000617:Aminoglycosides / Q000008:administration & dosage*; D000667:Ampicillin / Q000008:administration & dosage* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology; D002648:Child; D002675:Child, Preschool; D002981:Clindamycin / Q000008:administration & dosage*; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D005260:Female; D005839:Gentamicins / Q000008:administration & dosage; D006090:Gram-Negative Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D006094:Gram-Positive Bacteria / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D008297:Male; D011446:Prospective Studies; D013045:Species Specificity; D013407:Sulbactam / Q000627:therapeutic use; D014031:Tobramycin / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000617:Aminoglycosides; D005839:Gentamicins; D002981:Clindamycin; C035444:sultamicillin; D000667:Ampicillin; D013407:Sulbactam; D014031:Tobramycin